Pathological complete response after cisplatin neoadjuvant therapy is associated with the downregulation of DNA repair genes in BRCA1-associated triple-negative breast cancers. [electronic resource]
Producer: 20180212Description: 68662-68673 p. digitalISSN:- 1949-2553
- Adult
- Aged
- Antineoplastic Agents -- therapeutic use
- BRCA1 Protein -- genetics
- Chemotherapy, Adjuvant
- Cisplatin -- therapeutic use
- DNA Repair -- genetics
- Down-Regulation -- drug effects
- Female
- Gene Expression Profiling -- methods
- Gene Expression Regulation, Neoplastic -- drug effects
- Humans
- Middle Aged
- Neoadjuvant Therapy
- Remission Induction
- Triple Negative Breast Neoplasms -- drug therapy
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.